To prohibit taxpayer-funded gender transition procedures, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill prohibits the use of federal funds for gender transition procedures, including surgeries, hormone therapies, and puberty blockers. It applies to federal health facilities, federal employees providing healthcare, and health insurance plans receiving federal subsidies under the Affordable Care Act.
Who Benefits and How
- Taxpayers opposed to funding gender transition care: Federal funds cannot be used for these procedures, aligning spending with their preferences.
- Traditional healthcare providers: Those not offering gender transition services face no new compliance requirements.
Who Bears the Burden and How
- Transgender individuals: Lose access to federally-funded gender transition care through Medicare, Medicaid, VA, and military health systems.
- Healthcare providers specializing in gender transition care: Lose federal reimbursements and payments for these services.
- Federal health facilities and employees: Prohibited from providing these procedures within their scope of federal employment.
Key Provisions
- Bans federal funding for any gender transition procedures including surgeries, cross-sex hormones, and puberty blockers
- Prohibits federal health facilities and federal employees from providing gender transition procedures
- Bars health plans receiving ACA premium tax credits from covering gender transition procedures
- Defines exceptions for treating infections, injuries, diseases, or disorders caused by prior gender transition procedures
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Prohibits the use of federal funds for gender transition procedures, including through federal health facilities, federal employees, and federal health insurance subsidies.
Key Policy Areas
Healthcare, Federal Spending, Health Insurance
Primary Purpose
Prohibits the use of federal funds for gender transition procedures, including through federal health facilities, federal employees, and federal health insurance subsidies.
Policy Domains
Title I - Prohibiting Taxpayer-Funded Gender Transition Procedures
Identified Gains
Contextual inference, no direct clause citation- Taxpayers opposed to funding gender transition care
- Religious and conservative organizations
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Transgender individuals seeking federal healthcare
- Gender transition healthcare providers
Contextual inference, no direct clause citation
Title II - Application to the Affordable Care Act
Identified Gains
Contextual inference, no direct clause citation- Taxpayers opposed to funding gender transition care
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- ACA marketplace enrollees seeking gender transition coverage
- Health insurers offering gender transition coverage
Contextual inference, no direct clause citation
Chapter 4 - Prohibiting Taxpayer-Funded Gender Transition Procedures (Title 1 USC)
Identified Gains
Contextual inference, no direct clause citation- Taxpayers opposed to funding gender transition care
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Transgender individuals in federal healthcare systems
- Federal healthcare facilities
- Federal healthcare employees
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
IntroducedMr. Marshall (for himself, Mrs. Blackburn, Mr. Braun, Mr. Cramer, …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
ACA marketplace enrollees seeking gender transition coverage, Federal employees and beneficiaries with health insurance covering gender transition, Individuals able to pay for private coverage
Federal healthcare facilities (VA hospitals, military health, Indian Health Service), Federal healthcare facilities (VA hospitals, military medical facilities, IHS), Federal physicians and healthcare workers
Health insurers offering ACA plans with gender transition coverage, Health insurers offering gender transition coverage to federal programs, Private health insurers offering gender transition coverage
State and local governments seeking to provide gender transition coverage
Small employers offering health plans with gender transition coverage
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
Key Definitions
Terms defined in this bill
The biological indication of male or female in the context of reproductive potential or capacity, such as sex chromosomes, naturally occurring sex hormones, gonads, and non-ambiguous internal and external genitalia present at birth, without regard to an individual's psychological, chosen, or subjective experience of gender.
Testosterone or androgens given to biological females, or estrogen given to biological males, at doses profoundly larger or more potent than would normally occur naturally.
The psychological, behavioral, social, and cultural aspects of being male or female.
The process in which an individual goes from identifying with and living as a gender that corresponds to his or her biological sex to identifying with and living as a gender different from his or her biological sex.
Any medical or surgical service that seeks to alter or remove physical or anatomical characteristics typical for the individual's biological sex, or to instill or create physiological or anatomical characteristics that resemble a sex different from the individual's birth sex. Includes physician services, hospital services, prescribed drugs, puberty-blocking drugs, cross-sex hormones, and gender transition surgery. Excludes services to treat physical disorders or abnormal development, treatment for infections/injuries/diseases caused by prior gender transition procedures, and procedures undertaken for reasons other than gender transition.
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology